Tonix Pharmaceuticals Holding Corp.
TNXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001430306
In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $40.2K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +23 vs. previous quarter
- 102
- 13F valueReported value at the end of Q2 2026
- $119.4M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding TNXP, Q2 2026
No superinvestor reported holding TNXP at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Tonix Pharmaceuticals Holding Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 (view filing)8:00 AM ET | Aug 27 | 4 days | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +2.00K | $13.79 | +$27.6K | +22.2%11.0K after | |
| Aug 24, 2026 (view filing)8:00 AM ET | Aug 20 | 4 days | Bagger Richard HDirector | PPurchaseCommon Stock, par value $0.001 | +1.00K | $12.60 | +$12.6K | New position1.00K after | |
| Jun 15, 2026 (view filing) | Jun 12 | 3 days | Taylor Carolyn E.Director | PPurchaseCommon Stock, $0.001 par value | +1.42K | $10.55 | +$14.9K | +338.5%1.83K after | |
| Jun 9, 2026 (view filing) | Jun 9 | Same day | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +5.00K | $11.79 | +$59.0K | +124.8%9.01K after | |
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Stillwell Richard NewcombDirector | PPurchaseCommon Stock, $0.001 par value | +5.00K | $11.65 | +$58.3K | New position5.00K after | |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +5.00K | $12.62 | +$63.1K | +33.3%20.0K after | |
| Mar 18, 2026 (view filing) | Mar 18 | Same day | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +15.0K | $14.89 | +$223.3K | +1,500,000.0%15.0K after | |
| Aug 21, 2025 (view filing) | Aug 21 | Same day | Taylor Carolyn E.Director | PPurchaseCommon Stock, par value $0.001 | +418 | $36.03 | +$15.1K | New position418 after | |
| Aug 20, 2025 (view filing) | Aug 20 | Same day | Treco JamesDirector | PPurchaseCommon Stock, par value $0.001 | +250 | $36.00 | +$9.00K | New position250 after | |
| May 15, 2025 (view filing) | May 15 | Same day | Lederman SethChief Executive Officer | PPurchaseCommon Stock, $0.001 par value | +4.00K | $21.55 | +$86.2K | +80,000.0%4.00K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Tonix Pharmaceuticals Holding Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 1,398,041 | $17.8M | 0.00% | +429,864+44.4% | Added |
| Point72 Asset Management, L.P. | 1,166,752 | $14.9M | 0.02% | +1,041,338+830.3% | Added |
| Millennium Management LLC | 966,932 | $12.3M | 0.01% | +747,259+340.2% | Added |
| AQR Capital Management LLC | 882,595 | $11.3M | 0.00% | +721,387+447.5% | Added |
| Vanguard Capital Management LLC | 691,895 | $8.83M | 0.00% | +173,245+33.4% | Added |
| Jones Hill Capital LP | 625,428 | $7.98M | 1.70% | +173,312+38.3% | Added |
| Geode Capital Management, LLC | 395,260 | $5.04M | 0.00% | +81,969+26.2% | Added |
| Ishara Investments LP | 338,250 | $4.32M | 3.23% | +338,250 | New |
| State Street Corp | 271,374 | $3.46M | 0.00% | +40,767+17.7% | Added |
| UBS Group AG | 231,682 | $2.96M | 0.00% | +40.0% | Added |